Type 2N VWD

Prev
 1 / 20 
Next
Prev
 1 / 20 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • interpret type 3 VWD as functional absence of VWF rather than simply “very low VWF”
  • explain why type 3 VWD produces both mucocutaneous bleeding and hemophilia-like joint and muscle bleeding
  • distinguish type 3 VWD from severe type 1 VWD using laboratory findings, inheritance, and clinical implications
  • apply the rationale for VWF replacement therapy when endogenous VWF is absent
  • identify when long-term prophylaxis should be considered in patients with severe and recurrent bleeding
  • recognize clinical clues suggesting anti-VWF alloantibodies and understand why they alter management
  • integrate laboratory results, bleeding phenotype, and treatment principles to guide management of patients with type 3 VWD

A 24-year-old man has FVIII activity 16 IU/dL, VWF antigen 82 IU/dL, platelet-dependent VWF activity 76 IU/dL, and normal multimers. No pathogenic F8 variant is identified. His sister has low FVIII and postoperative bleeding. Which diagnosis should be strongly considered?

a
Type 1 VWD
Type 1 VWD usually shows proportional reduction of VWF antigen and activity, with FVIII tracking the low VWF level.
b
Type 2A VWD
Type 2A VWD usually shows reduced platelet-dependent activity relative to antigen and loss of high-molecular-weight multimers.
c
Type 2N VWD
This pattern should raise concern for type 2N VWD. FVIII is disproportionately low relative to VWF antigen and activity, multimers are normal, F8 testing is unrevealing, and both males and females appear affected.
d
Type 3 VWD
Type 3 VWD is characterized by absent or nearly absent VWF, not preserved VWF antigen and activity.

What is the primary functional defect in type 2N VWD?

a
Impaired VWF binding to platelet GPIbα
Impaired platelet GPIbα binding is more typical of type 2M VWD.
b
Loss of high-molecular-weight VWF multimers
Loss of high-molecular-weight multimers suggests type 2A or classic type 2B VWD.
c
Impaired VWF binding to FVIII
Type 2N VWD is caused by impaired binding of VWF to FVIII. FVIII is not stabilized normally and is cleared prematurely.
d
Absent VWF synthesis
Absent VWF synthesis suggests type 3 VWD.

Why can type 2N VWD mimic mild hemophilia A?

a
Both cause absent VWF antigen
VWF antigen is usually normal or only mildly reduced in classic type 2N VWD.
b
Both can present with low FVIII activity
Type 2N VWD and mild hemophilia A can both present with low FVIII activity and procedure-related or soft-tissue bleeding.
c
Severe mucocutaneous bleeding plus possible joint and muscle bleeding
Hemophilia A is X-linked; type 2N VWD is usually autosomal recessive.
d
Both show enhanced low-dose RIPA
Enhanced low-dose RIPA suggests increased VWF-platelet binding, as in type 2B VWD or platelet-type VWD.

Which laboratory relationship is the key clue to type 2N VWD?

a
FVIII disproportionately low relative to VWF antigen
The key clue is FVIII that is too low for the amount of VWF antigen present. The abnormal relationship is between FVIII and VWF.
b
VWF antigen higher than platelet count
Platelet count does not define type 2N VWD.
c
PT disproportionately prolonged relative to aPTT
Type 2N may prolong the aPTT if FVIII is low enough, but PT is not the key diagnostic relationship.
d
VWF activity higher than VWF antigen
The central issue is impaired FVIII carriage, not VWF activity exceeding antigen.

A patient has low FVIII, normal VWF antigen, normal platelet-dependent VWF activity, and a normal VWF activity-to-antigen ratio. Which statement is most accurate?

a
Type 2 VWD is excluded
A normal VWF activity-to-antigen ratio does not exclude type 2N VWD.
b
Type 2A VWD is confirmed
Type 2A VWD usually shows loss of high-molecular-weight multimers and low platelet-dependent activity relative to antigen.
c
Type 3 VWD is confirmed
Type 3 VWD requires absent or nearly absent VWF.
d
Type 2N VWD remains possible
Type 2N VWD remains possible because the defect is FVIII binding, not platelet binding. Platelet-dependent VWF activity and the activity-to-antigen ratio may be relatively preserved.

Which confirmatory test most directly evaluates the functional defect in type 2N VWD?

a
Bleeding time
Bleeding time is obsolete and nonspecific.
b
VWF assay
The VWF assay directly tests whether the patient’s VWF can bind FVIII normally.
c
Low-dose RIPA
Low-dose RIPA evaluates increased VWF-platelet interaction, useful for type 2B VWD or platelet-type VWD.
d
Platelet aggregation with ADP
Platelet aggregation with ADP evaluates platelet function, not VWF-FVIII binding.

Which inheritance pattern most strongly argues against simple mild hemophilia A and toward type 2N VWD?

a
Only males affected across maternal lineage
A pattern of affected males through the maternal line fits X-linked hemophilia A.
b
Both males and females affected with low FVIII in the same family
Type 2N VWD is usually autosomal recessive and can affect both males and females. That pattern should prompt reconsideration of a purely X-linked hemophilia A diagnosis.
c
No family history in an older man
Absence of family history is nonspecific.
d
Bleeding only in a maternal uncle
Bleeding in a maternal uncle may fit an X-linked inheritance pattern.

Why may FVIII-only replacement be less durable than expected in type 2N VWD?

a
VWF cannot stabilize FVIII normally
In type 2N VWD, VWF cannot bind and protect FVIII normally, so infused FVIII may have shortened survival.
b
FVIII is destroyed by platelets
Platelet-mediated destruction is not the mechanism.
c
FVIII cannot be measured accurately in type 2N
FVIII can be measured; the issue is shortened survival and interpretation.
d
Type 2N causes acquired inhibitors to FVIII
Type 2N VWD is not defined by acquired FVIII inhibitors.

What should a desmopressin trial assess in suspected type 2N VWD?

a
Only whether VWF antigen rises at 1 hour
A VWF antigen rise alone does not prove adequate FVIII stabilization.
b
Only whether the platelet count falls
Platelet-count decline is a major concern in type 2B VWD, not the main question in type 2N.
c
Whether FVIII rises enough and remains high enough for the intended challenge
The clinically important question is FVIII kinetics: whether FVIII rises to a hemostatic level and remains there long enough for the planned bleeding-risk situation.
d
Only whether PT normalizes
PT is not the relevant monitoring parameter.

Which finding would most strongly favor type 1 VWD over type 2N VWD?

a
FVIII 20 IU/dL with VWF antigen 85 IU/dL
FVIII is disproportionately low relative to VWF antigen, raising concern for type 2N VWD or hemophilia A.
b
FVIII 30 IU/dL with VWF antigen 28 IU/dL and proportionally low VWF activity
FVIII reduction that tracks with proportionally low VWF antigen and activity supports a quantitative VWF deficiency pattern, such as type 1 VWD.
c
Normal VWF activity-to-antigen ratio with normal multimers and no F8 variant
A normal VWF activity-to-antigen ratio and normal multimers do not exclude type 2N if FVIII is disproportionately low.
d
Both males and females in a family with low FVIII
Affected males and females may support autosomal inheritance, as in type 2N VWD.

A pregnant patient with known type 2N VWD has improved FVIII levels late in gestation. What is the best interpretation?

a
The diagnosis has resolved
Physiologic improvement in levels does not remove the diagnosis.
b
The patient must actually have hemophilia A
Pregnancy-related changes do not prove hemophilia A.
c
Postpartum bleeding risk is eliminated
Postpartum bleeding risk may re-emerge as levels fall toward baseline.
d
Pregnancy may improve levels temporarily, but the binding defect remains
Pregnancy may raise VWF and FVIII levels, but it does not remove the underlying FVIII-binding defect. Postpartum decline still matters.

Which statement best captures the central reasoning lesson of type 2N VWD?

a
Low FVIII always means hemophilia A
Low FVIII can also occur in type 2N VWD and other settings.
b
A normal VWF activity-to-antigen ratio excludes type 2 VWD
Type 2N VWD may have a normal VWF activity-to-antigen ratio.
c
When FVIII is low, ask whether VWF is failing to protect it
Type 2N VWD teaches that low FVIII can result from defective VWF-mediated FVIII stabilization.
d
Multimer analysis alone confirms type 2N
Multimers are usually normal in type 2N VWD and do not confirm the diagnosis.

Sort each finding into the diagnosis it most strongly supports.

activity with FVIII tracking the low VWF
affected brother and sister with low FVIII
proportionally low VWF antigen
low FVIII in a male with affected maternal male relatives
pathogenic F8 variant with X-linked family pattern
low FVIII with normal VWF antigen and normal VWF activity
normal VWF multimers and low FVIII-to-VWF antigen ratio
Type 2N VWD
Mild hemophilia A
Type 1 VWD

Match the finding with its best interpretation.

low FVIII with normal VWF antigen
FVIII rises after desmopressin but falls quickly
normal VWF activity-to-antigen ratio
does not exclude type 2N because platelet binding may be preserved
shows that peak response alone is not enough; duration matters
suggests impaired FVIII stabilization by VWF
Correct! Sorry, Incorrect.

Closing Note

Type 2N VWD is the hemophilia mimic that teaches why hemophilia biology depends on VWF. When FVIII is low, do not ask only whether FVIII is abnormal. Ask whether VWF is failing to protect it.

Prev
 1 / 20 
Next